VAERS reports by lot

Seqirus / CSL Flu lot 252665: VAERS reports

23 VAERS reports list lot 252665 as a Seqirus / CSL Flu vaccine, received between 2018-10-10 and 2020-05-07. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
23
Reports
9%
Marked serious
0
With a death outcome
7
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Musculoskeletal1319%
Neurological1116%
General / Systemic (non-local)1015%
Gastrointestinal913%
Injection-site / Local reaction913%
Cardiac / Cardiovascular69%
Thrombotic / Hematological34%
Respiratory34%
Dermatological (non-injection-site)23%
Allergic / Anaphylactic11%
Reproductive / Menstrual11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas3
New York2
Illinois2
Michigan2
Virginia1
Tennessee1
Indiana1
Missouri1
New Hampshire1
Alabama1
Ohio1
Oklahoma1

Reports by month received

2018-1012
2018-116
2019-011
2019-021
2019-051
2020-041
2020-051

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.